Ocular complications in children with diabetes mellitus

Ophthalmology

Volumn 122, Issue 12, 2015, Pages 2457-2464

  Geloneck, Megan M ^a   Forbes, Brian J ^a,b   Shaffer, James ^b   Ying, Gui Shuang ^b   Binenbaum, Gil ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; ASTIGMATISM; ASYMPTOMATIC DISEASE; CATARACT; CATARACT EXTRACTION; CHILD; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DIPLOPIA; DISEASE DURATION; DISEASE SEVERITY; EYE DISEASE; EYE EXAMINATION; EYE REFRACTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH MYOPIA; HUMAN; HYPERMETROPIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MICROVASCULAR PARALYTIC STRABISMUS; MYOPIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; OPHTHALMOPLEGIA; OPHTHALMOSCOPY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REFRACTION ERROR; RETROSPECTIVE STUDY; SCHOOL CHILD; STRABISMUS; VISUAL DISORDER; COMPLICATION; GLUCOSE BLOOD LEVEL; INFANT; METABOLISM; PHYSIOLOGY; PRESCHOOL CHILD; REFRACTIVE ERRORS; RISK FACTOR; VISION TEST; VISUAL ACUITY;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; MALE; REFRACTION, OCULAR; REFRACTIVE ERRORS; RETROSPECTIVE STUDIES; RISK FACTORS; STRABISMUS; VISION SCREENING; VISUAL ACUITY;

EID: 84948095578     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.07.010     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011 2011 US Department of Health & Human Services, Centers for Disease Control and Prevention Atlanta, GA
2. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group Ophthalmology 88 1981 583 600
3. Photocoagulation therapy for diabetic eye disease. Early Treatment Diabetic Retinopathy Study Research Group JAMA 254 1985 3086
4. American Academy of Ophthalmology Panel Preferred Practice Pattern 2014: Diabetic Retinopathy 2003 American Academy of Ophthalmology San Francisco
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med 329 1993 977 986
6. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group N Engl J Med 342 2000 381 389
7. R.W. Holl, G.E. Lang, M. Grabert, and et al. Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control J Pediatr 132 1998 790 794
8. P. Palmberg, M. Smith, S. Waltman, and et al. The natural history of retinopathy in insulin-dependent juvenile-onset diabetes Ophthalmology 88 1981 613 618
9. R. Klein, B.E. Klein, S.E. Moss, and et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years Arch Ophthalmol 102 1984 520 526
10. J.M. Hermann, H.P. Hammes, B. Rami-Merhar, and et al. HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patients PLoS One 9 2014 e91137
11. J.N. Harvey, and B. Allagoa The long-term renal and retinal outcome of childhood-onset Type 1 diabetes Diabet Med 21 2004 26 31
12. M.C. Monti, J.T. Lonsdale, C. Montomoli, and et al. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes J Clin Endocrinol Metab 92 2007 4650 4655
13. M. Svensson, J.W. Eriksson, and G. Dahlquist Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden Diabetes Care 27 2004 955 962
14. K.C. Donaghue, F. Chiarelli, D. Trotta, and et al. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications Pediatr Diabetes 8 2007 163 170
15. G.T. Lueder, S. Pradhan, and N.H. White Risk of retinopathy in children with type 1 diabetes mellitus before 2 years of age Am J Ophthalmol 140 2005 930 931
16. K.C. Donaghue, J.M. Fairchild, A. Chan, and et al. Diabetes microvascular complications in prepubertal children J Pediatr Endocrinol Metab 10 1997 579 585
17. A. Flack, M.L. Kaar, and L. Laatikainen A prospective, longitudinal study examining the development of retinopathy in children with diabetes Acta Paediatr 85 1996 313 319
18. A. Kernell, I. Dedorsson, B. Johansson, and et al. Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study Diabetologia 40 1997 307 310
19. M. Kubin, P. Tossavainen, V. Hannula, and et al. Prevalence of retinopathy in Finnish children and adolescents with type 1 diabetes: a cross-sectional population-based retrospective study Arch Dis Child 96 2011 963 968
20. C.E. Kullberg, M. Abrahamsson, H.J. Arnqvist, and et al. Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes Diabet Med 19 2002 924 931
21. A. Maguire, A. Chan, J. Cusumano, and et al. The case for biennial retinopathy screening in children and adolescents Diabetes Care 28 2005 509 513
22. N. Minuto, V. Emmanuele, M. Vannati, and et al. Retinopathy screening in patients with type 1 diabetes diagnosed in young age using a non-mydriatic digital stereoscopic retinal imaging J Endocrinol Invest 35 2012 389 394
23. T. Lecaire, M. Palta, H. Zhang, and et al. Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study Am J Epidemiol 164 2006 143 150
24. M. Henricsson, L. Nystrom, G. Blohme, and et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS) Diabetes Care 26 2003 349 354
25. E.J. Mayer-Davis, C. Davis, J. Saadine, and et al. Diabetic retinopathy in the SEARCH for Diabetes in Youth Cohort: a pilot study Diabet Med 29 2012 1148 1152
26. B.E. Klein, R. Klein, and S.E. Moss Prevalence of cataracts in a population-based study of persons with diabetes mellitus Ophthalmology 92 1985 1191 1196
27. E.L. Montgomery, and J.A. Batch Cataracts in insulin-dependent diabetes mellitus: sixteen years' experience in children and adolescents J Paediatr Child Health 34 1998 179 182
28. M.E. Wilson Jr., A.V. Levin, R.H. Trivedi, and et al. Cataract associated with type-1 diabetes mellitus in the pediatric population J AAPOS 11 2007 162 165
29. Eye examination in infants, children, and young adults by pediatricians Pediatrics 111 4 Pt 1 2003 902 907
30. Vision screening for children 1 to 5 years of age: US Preventive Services Task Force Recommendation statement Pediatrics 127 2011 340 346
31. G.D. Eng, W. Hung, G.P. August, and M.D. Smokvina Nerve conduction velocity determinations in juvenile diabetes: continuing study of 190 patients Arch Phys Med Rehabil 57 1976 1 5
32. G.T. Lueder, and J. Silverstein Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus Pediatrics 116 2005 270 273
33. V. Snow, K.B. Weiss, and C. Mottur-Pilson The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus Ann Intern Med 138 2003 587 592